NAV
₹337.2776
as of 29 Sept 2026
Expense Ratio
1.25%
Viewing Direct · Growth
Lumpsum returns (CAGR)
- 1Y
- +2.76%
- 3Y
- +10.57%
- 5Y
- +11.05%
- Since Inception
- +17.58%
SIP returns (XIRR)
- 1Y
- +0.50%
- 3Y
- +5.02%
- 5Y
- +10.57%
- Since Inception
- +14.10%
Performance Comparison
Sectoral allocation
as of 31 Aug 2026- Pharmaceuticals & Biotechnology9.70%
- Banks8.61%
- Industrial Products8.20%
- Retailing6.42%
- Finance6.26%
- Consumer Durables5.96%
- IT - Software5.82%
- Electrical Equipment5.70%
- Auto Components5.34%
- Capital Markets5.18%
- Chemicals & Petrochemicals3.20%
- Financial Technology (Fintech)3.08%
Each sector links to the mutual funds most exposed to it.
Thinking about UTI Mid Cap Fund · Direct · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Fund Details
Fund HouseUTI Mutual Fund
CategoryMid Cap
Launch Date02 Jan 2013
AMFI Code120726
Transaction facts
Min. Lumpsum₹5,000
Min. SIP₹500
Available transactions
PurchaseSIPRedeemSWPSwitchSTPDemat
Portfolio holdings
as of 31 Aug 2026
portfolio shared with UTI Mid Cap Fund - Direct Plan - IDCW
Holding% NAV
- 1Coforge Ltd3.26%
- 2Pb Fintech Ltd3.08%
- 3Au Small Finance Bank Ltd2.76%
- 4Apl Apollo Tubes Ltd2.43%
- 5Hero Motocorp Ltd.2.17%
- 6Aurobindo Pharma Ltd.2.15%
- 7Federal Bank Ltd.2.08%
- 8Ajanta Pharma Ltd.2.07%
- 9Polycab India Ltd2.07%
- 10Shriram Finance Ltd2.00%
Rows per page· 80 total
Page 1/8
What this fund does
UTI Mid Cap Fund · Direct · Growth seeks to generate long-term capital appreciation by investing in mid-cap companies — ranked 101st to 250th by market capitalisation. These companies offer a balance of growth potential and relative stability, with wider price swings than large-caps.
About This Fund
UTI Mid Cap Fund · Direct · Growth is a Mid Cap mutual fund offered by UTI Mutual Fund. The fund has been operational for over 13 years. The current expense ratio is 1.25%.